Teva Pharmaceutical Indus... (TEVA)
Teva Pharmaceutical Industries Max Pain By Strike
TEVA trades at $17.62, 10.1% above the near-term max pain of $16 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($9-$17), reflecting growing call interest at higher strikes. Key magnetic zone at 17 where 9 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Teva Pharmaceutical Industries Max Pain By Expiry
Max pain for TEVA shows an upward trend from 9 to 17, suggesting bullish positioning in longer-dated options. The 50% spread signals divergent expectations across timeframes. Most levels below 17.62 may cap rallies. Strong magnetic level at 17 (9 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 16 | -1.62 (-9.19%) |
| Aug 22, 2025 | 16.5 | -1.12 (-6.36%) |
| Aug 29, 2025 | 16 | -1.62 (-9.19%) |
| Sep 5, 2025 | 15 | -2.62 (-14.87%) |
| Sep 12, 2025 | 16.5 | -1.12 (-6.36%) |
| Sep 19, 2025 | 16 | -1.62 (-9.19%) |
| Sep 26, 2025 | 16.5 | -1.12 (-6.36%) |
| Oct 17, 2025 | 9 | -8.62 (-48.92%) |
| Dec 19, 2025 | 17 | -0.62 (-3.52%) |
| Jan 16, 2026 | 17 | -0.62 (-3.52%) |
| Feb 20, 2026 | 17 | -0.62 (-3.52%) |
| Mar 20, 2026 | 17 | -0.62 (-3.52%) |
| Jun 18, 2026 | 17 | -0.62 (-3.52%) |
| Sep 18, 2026 | 17 | -0.62 (-3.52%) |
| Jan 15, 2027 | 15 | -2.62 (-14.87%) |